feed,title,long_url,short_url
SSRN,"Immunogenicity and Tolerability of BBV154 (iNCOVACC®), an Intranasal SARS-CoV-2 Vaccine, Compared with Intramuscular Covaxin® in Healthy Adults: A Randomised, Open-Label, Phase 3 Clinical Trial",https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4342771,
